The vaccine setback pushed the markets lower - Tuesday Review, October 13

By: Miguel A. Rodriguez

11:13, 14 October 2020

Investors didn't enjoy the temporary halt in the progress of a COVID-19 vaccine

The US

The benchmarks disregarded the promising beginning of the latest earnings season and focused on the fact that another significant pharma company halted the trials of a potential #COVID-19 vaccine. USA30 fell 0.55% while USA500 was down 0.61%. TECH100 slipped 0.10%.

Crude Oil and Brent gained 0.4%, ending the session at $39.56 per barrel and $41.88. 

Gold lost 1.8% to $1,894.60 per ounce.

The Dollar Index rose 0.5% to 93.55.


Asia and Australia

Japan225 lost 0.07% amid the hiccup in the trials of a potential COVID-19 #vaccine from Johnson & Johnson.

Down under, Australia200 gained 1.18%, after the country is seeking to resolve the ban imposed by China on the Australian coal imports.

USD/JPY gained 0.24% to 105.55.



Germany30 and UK100 lost 0.4% each. France40 fell 0.5%. The drop was caused by the fact that the new wave of infections could negatively impact the ongoing economic recovery.

EUR/USD traded at 1.1785 after it lost 0.2%.


Share this article

This information prepared by is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation, or the particular needs of any recipient.You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation, or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.This information may not be published, circulated, reproduced, or distributed in whole or in part to any other person without the Company’s prior written consent.
Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of Financial Services (Pty) Ltd trading as CAPEX.COM/ZA acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via CAPEX.COM/ZA, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15.  Magnasale Trading Ltd is the principal to the CFD purchased by investors.